LFG
RYTM icon

Larson Financial Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

Larson Financial Group’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.52K Sell
52
-25
-32% -$2.43K ﹤0.01% 2655
2025
Q4 		$8.24K Buy
77
+49
+175% +$5.2K ﹤0.01% 2227
2025
Q3 		$2.83K Buy
+28
New +$2.6K ﹤0.01% 2570

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Larson Financial Group's RYTM Position: Q1 2026 in Review

Larson Financial Group reduced its Rhythm Pharmaceuticals (RYTM) stake by 32% in Q1 2026, selling an estimated $2.43K and leaving 52 shares worth $4.52K. The position accounts for ﹤0.01% of the portfolio, ranked #2655.

Larson Financial Group first reported a position in RYTM in Q3 2025 and has held it in 3 quarters since. The position peaked at $8.24K in Q4 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Larson Financial Group held 52 shares of Rhythm Pharmaceuticals worth $4.52K as of Q1 2026.
  • Larson Financial Group sold 25 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $2.43K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2655 holding.
  • Larson Financial Group first reported a position in Rhythm Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Larson Financial Group's Rhythm Pharmaceuticals position peaked at $8.24K in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.